pubmed-article:10745233 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10745233 | lifeskim:mentions | umls-concept:C0376574 | lld:lifeskim |
pubmed-article:10745233 | lifeskim:mentions | umls-concept:C0019158 | lld:lifeskim |
pubmed-article:10745233 | lifeskim:mentions | umls-concept:C0267797 | lld:lifeskim |
pubmed-article:10745233 | lifeskim:mentions | umls-concept:C1314792 | lld:lifeskim |
pubmed-article:10745233 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
pubmed-article:10745233 | lifeskim:mentions | umls-concept:C0022277 | lld:lifeskim |
pubmed-article:10745233 | lifeskim:mentions | umls-concept:C1704788 | lld:lifeskim |
pubmed-article:10745233 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:10745233 | pubmed:dateCreated | 2000-7-24 | lld:pubmed |
pubmed-article:10745233 | pubmed:abstractText | The role of GBV-C/HGV in the aetiology of acute non A-E hepatitis and its impact on the course of acute hepatitis of defined aetiology were investigated by detecting viral RNA by RT-PCR and antibody to the E2 protein of GB virus C (anti-E2) by EIA. Ninety-eight patients with acute nonA-E hepatitis, 35 patients with acute hepatitis A, 63 with acute hepatitis B, 29 with acute hepatitis C and 270 controls were enrolled in this study. The prevalence of GBV-C/HGV RNA was similar among patients with acute nonA-E hepatitis (3.1%), with acute hepatitis A (2.9%), and controls (3.7%), but significantly higher (P < 0.05) among those with hepatitis B or C (19.0% and 48.3%, respectively). Similar figures were obtained considering the total rate of GBV-C/HGV exposure (viral RNA or anti-E2 positivity). The majority (24/30 or 80%) of GBV-C/HGV RNA positive patients reported a parenteral source of exposure whereas the remaining 20% denied having known risk factors. The liver function test values and the rate of chronic hepatitis B and C were similar in patients co-infected and in those not co-infected with GBV-C/HGV. This study excludes a significant role of GBV-C/HGV infection in the aetiology of acute nonA-E hepatitis in Italy. Concomitant GBV-C/HGV and HBV or HCV infection does not worsen the clinical course of illness among patients with acute hepatitis. | lld:pubmed |
pubmed-article:10745233 | pubmed:language | eng | lld:pubmed |
pubmed-article:10745233 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10745233 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10745233 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10745233 | pubmed:month | May | lld:pubmed |
pubmed-article:10745233 | pubmed:issn | 0146-6615 | lld:pubmed |
pubmed-article:10745233 | pubmed:author | pubmed-author:MazzottaFF | lld:pubmed |
pubmed-article:10745233 | pubmed:author | pubmed-author:ZanettiA RAR | lld:pubmed |
pubmed-article:10745233 | pubmed:author | pubmed-author:FabrisPP | lld:pubmed |
pubmed-article:10745233 | pubmed:author | pubmed-author:TanziEE | lld:pubmed |
pubmed-article:10745233 | pubmed:author | pubmed-author:TosittiGG | lld:pubmed |
pubmed-article:10745233 | pubmed:author | pubmed-author:Roman?LL | lld:pubmed |
pubmed-article:10745233 | pubmed:copyrightInfo | Copyright 2000 Wiley-Liss, Inc. | lld:pubmed |
pubmed-article:10745233 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10745233 | pubmed:volume | 61 | lld:pubmed |
pubmed-article:10745233 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10745233 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10745233 | pubmed:pagination | 59-64 | lld:pubmed |
pubmed-article:10745233 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:meshHeading | pubmed-meshheading:10745233... | lld:pubmed |
pubmed-article:10745233 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10745233 | pubmed:articleTitle | GBV-C/hepatitis G virus in acute nonA-E hepatitis and in acute hepatitis of defined aetiology in Italy. | lld:pubmed |
pubmed-article:10745233 | pubmed:affiliation | Institute of Virology, University of Milan, Milan, Italy. | lld:pubmed |
pubmed-article:10745233 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10745233 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10745233 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10745233 | lld:pubmed |